A newly identified molecular mechanism reveals how neurons weigh survival against repair after injury.
Scientists at the Icahn School of Medicine at Mount Sinai have identified a molecular switch in neurons that limits the regrowth of damaged axons. Their study, published in Nature, suggests that blocking a protein known as the aryl hydrocarbon receptor (AHR) could promote nerve regeneration and help restore function after injuries to peripheral nerves or the spinal cord.
Axons are long fibers that transmit signals between nerve cells, or neurons, throughout the central and peripheral nervous systems. These structures are essential for communication within the body. When axons are damaged, recovery depends on the neuron’s ability to regrow them.
In adult mammals, this ability is very limited. As a result, injuries to nerves or the spinal cord often lead to lasting or permanent loss of movement or sensation. Researchers have spent years trying to understand why this repair process is so constrained.
A Molecular Brake on Regeneration
The study found that AHR plays a central role in controlling how neurons respond to injury.
“When neurons are injured, they must deal with stress while also trying to regrow their axons,” said Hongyan Zou, MD, PhD, Professor of Neurosurgery, and Neuroscience, at the Icahn School of Medicine at Mount Sinai and the study’s senior author. “We discovered that AHR functions like a brake that shifts neurons toward managing stress rather than rebuilding damaged connections.”

Experiments showed that active AHR signaling slows axon regrowth. When researchers removed AHR or blocked it with drugs, damaged axons regenerated more effectively. In mouse models of peripheral nerve and spinal cord injury, inhibiting AHR also improved both movement and sensory recovery.
Balancing Survival and Growth
Further analysis revealed why this happens. After injury, AHR helps neurons maintain protein quality through a process called proteostasis. This response protects cells under stress but limits the production of new proteins needed for repair.
When AHR is turned off, neurons shift priorities. They increase protein production and activate pathways that support axon growth. The team also found that this regenerative response depends on another factor, HIF-1α, which controls genes involved in metabolism and tissue repair.
“This discovery shows that neurons use AHR to balance survival and regeneration,” Dr. Zou explained. “By releasing this brake, we can push neurons into a state that favors repair.”
A Dual Role for an Environmental Sensor
AHR was first identified as a receptor that detects environmental toxins, known as xenobiotics. The new findings show it also has an important internal role, helping neurons integrate environmental signals with their ability to regenerate after injury.
This research is an early step toward potential therapies. Several drugs that block AHR are already in clinical trials for other conditions, raising the possibility that they could be tested for nerve and spinal cord injuries.
However, more work is needed before this approach can be used in patients. Future studies will explore how well AHR inhibitors work across different types of neural damage, determine optimal timing and dosage, and examine their effects on other cells after injury.
The Mount Sinai team plans to test both AHR-blocking drugs and gene therapy approaches aimed at reducing AHR activity in neurons. The goal is to see whether these strategies can further enhance axon regrowth and improve recovery after spinal cord injury, stroke, and other neurological disorders.
Reference: “AhR inhibition promotes axon regeneration via a stress–growth switch” by Dalia Halawani, Yiqun Wang, Jiaxi Li, Daniel Halperin, Haofei Ni, Molly Estill, Aarthi Ramakrishnan, Li Shen, Arthur Sefiani, Cédric G. Geoffroy, Roland H. Friedel and Hongyan Zou, 1 April 2026, Nature.
DOI: 10.1038/s41586-026-10295-z
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]















